rs1555742184

Variant names:

• chr19-33301983-C-A
• rs1555742184
• NM_004364.5:c.432G>T

Your query was ambiguous. Multiple possible variants found:

• chr19-33301983-C-A
• chr19-33301983-C-G
• chr19-33301983-C-T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_Strong BS2

The NM_004364.5(CEBPA):​c.432G>T​(p.Glu144Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000312 in 1,058,454 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E144G) has been classified as Likely benign.

• Frequency:
  • Genomes: not found (cov: 32)
  • Exomes 𝑓: 0.000031 (0 hom.)
• Consequence: CEBPA NM_004364.5 missense
• Clinical Significance: Uncertain significance criteria provided, multiple submitters, no conflicts U:2
• Conservation: PhyloP100: 0.745
• Publications: 0 publications found

Genes affected

CEBPA (HGNC:1833): (CCAAT enhancer binding protein alpha) This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain and recognizes the CCAAT motif in the promoters of target genes. The encoded protein functions in homodimers and also heterodimers with CCAAT/enhancer-binding proteins beta and gamma. Activity of this protein can modulate the expression of genes involved in cell cycle regulation as well as in body weight homeostasis. Mutation of this gene is associated with acute myeloid leukemia. The use of alternative in-frame non-AUG (GUG) and AUG start codons results in protein isoforms with different lengths. Differential translation initiation is mediated by an out-of-frame, upstream open reading frame which is located between the GUG and the first AUG start codons. [provided by RefSeq, Dec 2013]

CEBPA-DT (HGNC:25710): (CEBPA divergent transcript)

ENSG00000267727 (HGNC:):

ACMG classification

Our verdict: Benign. The variant received -8 ACMG points.

• BP4: Computational evidence support a benign effect (MetaRNN=0.06722683).
• BS2: High AC in GnomAdExome4 at 33 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004364.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	CEBPA	NM_004364.5	MANE Select	c.432G>T	p.Glu144Asp	missense	Exon 1 of 1	NP_004355.2
	CEBPA	NM_001287424.2		c.537G>T	p.Glu179Asp	missense	Exon 1 of 1	NP_001274353.1
	CEBPA	NM_001287435.2		c.390G>T	p.Glu130Asp	missense	Exon 1 of 1	NP_001274364.1

Ensembl Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	CEBPA	ENST00000498907.3	TSL:6 MANE Select	c.432G>T	p.Glu144Asp	missense	Exon 1 of 1	ENSP00000427514.1
	CEBPA-DT	ENST00000718467.1		n.46+184C>A		intron	N/A
	ENSG00000267727	ENST00000587312.1	TSL:3	n.*43C>A		downstream_gene	N/A

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome AF: 0.0000312 AC: 33 AN: 1058454 Hom.: 0 Cov.: 33 AF XY: 0.0000357 AC XY: 18 AN XY: 504000

African (AFR) AF: 0.00 AC: 0 AN: 21230

American (AMR) AF: 0.00 AC: 0 AN: 7362

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 12550

East Asian (EAS) AF: 0.00 AC: 0 AN: 22604

South Asian (SAS) AF: 0.00 AC: 0 AN: 24468

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 23448

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 2724

European-Non Finnish (NFE) AF: 0.0000354 AC: 32 AN: 903382

Other (OTH) AF: 0.0000246 AC: 1 AN: 40686

GnomAD4 genome Cov.: 32

ClinVar

ClinVar submissions as Germline

Significance: Uncertain significance

Revision: criteria provided, multiple submitters, no conflicts

Pathogenic	VUS	Benign	Condition
-	1	-	Acute myeloid leukemia (1)
-	1	-	Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.13
BayesDel_addAF	Benign	-0.32	T
BayesDel_noAF	Benign	-0.70
CADD	Benign	18
DANN	Benign	0.95
DEOGEN2	Benign	0.19	T
Eigen	Benign	-0.87
Eigen_PC	Benign	-0.71
FATHMM_MKL	Benign	0.70	D
LIST_S2	Benign	0.56	T
M_CAP	Pathogenic	0.69	D
MetaRNN	Benign	0.067	T
MetaSVM	Benign	-0.97	T
MutationAssessor	Benign	-0.69	N
PhyloP100		0.74
PrimateAI	Pathogenic	0.94	D
PROVEAN	Benign	-0.43	N
REVEL	Benign	0.031
Sift	Benign	0.70	T
Sift4G	Benign	0.69	T
Polyphen		0.0020	B
Vest4		0.051
MutPred		0.23		Loss of sheet (P = 0.0457)
MVP		0.12
ClinPred		0.12	T
GERP RS		-0.78
Varity_R		0.086
gMVP		0.21
Mutation Taster		=81/19	polymorphism

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs1555742184; hg19: chr19-33792889; COSMIC: COSV105881780;